Ipatasertib (GDC-0068) is a potent, ATP-competitive AKT inhibitor. It affects PI3K/AKT/mTOR signaling pathways by binding to the AKT ATP-binding pocket, effectively inhibiting tumor cell proliferation, migration, and invasion, and promoting apoptosis.
Ipatasertib (GDC-0068) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Ipatasertib (GDC-0068) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Ipatasertib (GDC-0068) Mechanism of Action: AKT Inhibition in Breast Cancer Cell Research
- Ipatasertib (GDC-0068) Clinical Trials
- Ipatasertib (GDC-0068) Working Concentration | Cell Culture | Treatment
- Ipatasertib (GDC-0068) Solubility in DMSO
- Ipatasertib (GDC-0068) Stock Solution
- Ipatasertib (GDC-0068) Storage
- Ipatasertib (GDC-0068) Stability
- Ipatasertib (GDC-0068) Combination Database
- Ipatasertib (GDC-0068) Molecular Weight
- Ipatasertib (GDC-0068) SMILES
- Ipatasertib (GDC-0068) CAS Number
- Ipatasertib (GDC-0068) Chemical Structure (2D and 3D)
- Ipatasertib (GDC-0068) Sigma (BL3H1F1C94B1)? Try a better option.
- Ipatasertib (GDC-0068) MedChemExpress (HY-15186)? Try a better option.
- Ipatasertib (GDC-0068) APExBIO (A3006)? Try a better option.
- Ipatasertib (GDC-0068) Cayman (18412)? Try a better option.
- Ipatasertib (GDC-0068) SDS｜MSDS